• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Thursday

    8/3/23 2:45:15 PM ET
    $WLGS
    $WPC
    $XNCR
    $ZI
    Engineering & Construction
    Consumer Discretionary
    Real Estate Investment Trusts
    Real Estate
    Get the next $WLGS alert in real time by email

     

    During Thursday's session, 92 stocks hit new 52-week lows.

    Intriguing Points From Today's 52-Week Lows:

    • Pfizer (NYSE:PFE) was the biggest company on a market cap basis to set a new 52-week low.
    • BitNile Metaverse (NASDAQ:BNMV) was the smallest firm by market cap to set a new 52-week low.
    • Aravive (NASDAQ:ARAV) made the largest move down on the session, with shares plummeting 71.75% to reach its 52-week low.
    • Senstar Tech (NASDAQ:SNT) saw the biggest bounce back on, as shares traded up 0.0% to rebound after it hit its new 52-week low.

    Stocks that set new 52-week lows on Thursday are as follows:

    • Pfizer (NYSE:PFE) stock set a new 52-week low of $34.92 on Thursday, moving down 0.57%.
    • Moderna (NASDAQ:MRNA) stock broke to a new 52-week low of $108.26 on Thursday. Shares of the company traded up 1.35%.
    • Extra Space Storage (NYSE:EXR) stock achieved a new 52-week low on Thursday morning, hitting $135.15 and moving down 0.17%.
    • TELUS (NYSE:TU) shares hit a yearly low of $17.12. The stock was down 0.81% on the session.
    • W.P. Carey (NYSE:WPC) shares moved down 0.45% on Thursday to hit a new 52-week low of $65.93, drifting down 0.45%.
    • Avangrid (NYSE:AGR) stock hit a yearly low of $35.30. The stock was down 2.23% for the day.
    • American Finl Gr (NYSE:AFG) shares set a new 52-week low of $109.98. The stock traded down 9.95%.
    • ZoomInfo Technologies (NASDAQ:ZI) stock hit a new 52-week low of $18.25. The stock was up 1.06% on the session.
    • UGI (NYSE:UGI) stock broke to a new 52-week low of $25.20 on Thursday. Shares of the company traded down 5.07%.
    • NextEra Energy Partners (NYSE:NEP) stock hit a new 52-week low of $51.02. The stock was down 3.28% on the session.
    • Ormat Technologies (NYSE:ORA) shares hit a yearly low of $76.71. The stock was down 2.34% on the session.
    • Marriott Vacations (NYSE:VAC) shares reached a new 52-week low of $109.27 on Thursday morning, moving down 11.37%.
    • DXC Technology (NYSE:DXC) stock drifted down 28.74% on Thursday morning to hit a new 52-week low of $19.23.
    • Black Hills (NYSE:BKH) shares set a new 52-week low of $56.72. The stock traded down 3.71%.
    • NovoCure (NASDAQ:NVCR) shares were down 1.89% for the day, having made a 52-week low of $29.31.
    • Clearway Energy (NYSE:CWEN) stock hit a yearly low of $24.63. The stock was down 1.78% for the day.
    • Fortrea Holdings (NASDAQ:FTRE) stock hit a yearly low of $29.34. The stock was down 1.07% for the day.
    • Daqo New Energy (NYSE:DQ) stock set a new 52-week low of $33.40 on Thursday, moving down 6.19%.
    • Staar Surgical (NASDAQ:STAA) stock set a new 52-week low of $45.00 on Thursday, moving down 9.27%.
    • Spirit AeroSystems Hldgs (NYSE:SPR) stock drifted down 7.63% on Thursday morning to hit a new 52-week low of $20.60.
    • Equity Commonwealth (NYSE:EQC) shares fell to $19.27 on Thursday, setting a new 52-week low with a shift of down 1.33%.
    • Beam Therapeutics (NASDAQ:BEAM) shares hit a yearly low of $27.30. The stock was down 3.01% on the session.
    • Impinj (NASDAQ:PI) stock drifted down 2.62% on Thursday morning to hit a new 52-week low of $60.74.
    • Shutterstock (NYSE:SSTK) shares were down 1.45% for the day, having made a 52-week low of $41.76.
    • Northwest Natural Hldg (NYSE:NWN) stock hit a yearly low of $41.48. The stock was down 0.24% for the day.
    • Xencor (NASDAQ:XNCR) shares moved down 0.64% on Thursday to hit a new 52-week low of $23.23, drifting down 0.64%.
    • Nu Skin Enterprises (NYSE:NUS) stock dropped to a yearly low on Thursday of $27.12. Shares traded down 0.54%.
    • Genesis Energy (NYSE:GEL) stock set a new 52-week low of $8.35 on Thursday, moving down 10.68%.
    • Infinera (NASDAQ:INFN) shares were down 3.51% for the day, having made a 52-week low of $4.10.
    • Sinclair (NASDAQ:SBGI) shares set a new 52-week low of $11.90. The stock traded down 5.78%.
    • CommScope Hldg Co (NASDAQ:COMM) stock hit $3.32 on Thursday morning, setting a new 52-week low for a change of down 21.15%.
    • Nerdwallet (NASDAQ:NRDS) stock drifted down 10.5% on Thursday morning to hit a new 52-week low of $7.62.
    • AerSale (NASDAQ:ASLE) shares set a new 52-week low of $13.74. The stock traded up 1.16%.
    • IntL Money Express (NASDAQ:IMXI) shares were down 3.3% for the day, having made a 52-week low of $18.53.
    • Summit Hotel Properties (NYSE:INN) stock broke to a new 52-week low of $5.46 on Thursday. Shares of the company traded down 3.31%.
    • ModivCare (NASDAQ:MODV) shares moved down 3.89% on Thursday to hit a new 52-week low of $34.49, drifting down 3.89%.
    • American Lithium (NASDAQ:AMLI) stock hit a new 52-week low of $1.71. The stock was down 2.56% on the session.
    • Fate Therapeutics (NASDAQ:FATE) shares set a new yearly low of $3.61 this morning. The stock was down 3.14% on the session.
    • Repare Therapeutics (NASDAQ:RPTX) shares fell to $8.20 on Thursday, setting a new 52-week low with a shift of up 1.68%.
    • Luxfer Holdings (NYSE:LXFR) shares moved down 2.29% on Thursday to hit a new 52-week low of $12.12, drifting down 2.29%.
    • Vanda Pharma (NASDAQ:VNDA) stock hit a new 52-week low of $5.45. The stock was up 1.64% on the session.
    • 2seventy bio (NASDAQ:TSVT) stock hit a new 52-week low of $6.19. The stock was down 2.95% on the session.
    • Transcontinental Realty (NYSE:TCI) shares made a new 52-week low of $33.95 on Thursday. The stock was down 1.42% for the day.
    • BRC (NYSE:BRCC) shares fell to $4.11 on Thursday, setting a new 52-week low with a shift of down 0.82%.
    • Braemar Hotels & Resorts (NYSE:BHR) stock hit $3.25 on Thursday morning, setting a new 52-week low for a change of down 1.87%.
    • NGM Biopharmaceuticals (NASDAQ:NGM) stock hit a new 52-week low of $2.09. The stock was up 2.57% on the session.
    • Inogen (NASDAQ:INGN) stock set a new 52-week low of $7.43 on Thursday, moving down 0.53%.
    • Complete Solaria (NASDAQ:CSLR) stock broke to a new 52-week low of $3.12 on Thursday. Shares of the company traded down 3.41%.
    • Zevia (NYSE:ZVIA) stock achieved a new 52-week low on Thursday morning, hitting $2.58 and moving down 0.57%.
    • Vicarious Surgical (NYSE:RBOT) stock dropped to a yearly low on Thursday of $0.90. Shares traded down 41.93%.
    • PaySign (NASDAQ:PAYS) stock drifted down 0.56% on Thursday morning to hit a new 52-week low of $1.74.
    • OFS Credit Co (NASDAQ:OCCI) stock hit a yearly low of $7.77. The stock was down 0.89% for the day.
    • Allot (NASDAQ:ALLT) shares were down 3.67% for the day, having made a 52-week low of $2.29.
    • MSP Recovery (NASDAQ:LIFW) shares hit a yearly low of $0.17. The stock was down 0.06% on the session.
    • Marti Techs (AMEX:MRT) shares hit a yearly low of $1.13. The stock was down 6.42% on the session.
    • Anitra (AMEX:AZTR) stock hit $3.18 on Thursday morning, setting a new 52-week low for a change of down 1.85%.
    • Neonode (NASDAQ:NEON) stock hit a new 52-week low of $2.00. The stock was down 40.71% on the session.
    • Senstar Tech (NASDAQ:SNT) stock achieved a new 52-week low on Thursday morning, hitting $1.15 and moving 0.0% (flat).
    • Trio Petroleum (AMEX:TPET) stock set a new 52-week low of $0.73 on Thursday, moving down 3.86%.
    • Datasea (NASDAQ:DTSS) shares hit a yearly low of $0.63. The stock was down 8.87% on the session.
    • Cosmos Health (NASDAQ:COSM) stock set a new 52-week low of $1.16 on Thursday, moving down 3.88%.
    • WANG & LEE Group (NASDAQ:WLGS) shares set a new 52-week low of $0.84. The stock traded down 7.62%.
    • Treasure Global (NASDAQ:TGL) shares hit a yearly low of $0.63. The stock was down 0.06% on the session.
    • KWESST Micro Systems (NASDAQ:KWE) shares made a new 52-week low of $1.91 on Thursday. The stock was up 1.71% for the day.
    • ShiftPixy (NASDAQ:PIXY) shares hit a yearly low of $0.95. The stock was down 1.88% on the session.
    • Golden Minerals (AMEX:AUMN) shares were down 1.61% for the day, having made a 52-week low of $1.18.
    • Nogin (NASDAQ:NOGN) stock achieved a new 52-week low on Thursday morning, hitting $0.82 and moving down 3.46%.
    • Taoping (NASDAQ:TAOP) shares set a new yearly low of $3.52 this morning. The stock was up 3.0% on the session.
    • Biolase (NASDAQ:BIOL) stock hit $4.65 on Thursday morning, setting a new 52-week low for a change of down 7.63%.
    • Soligenix (NASDAQ:SNGX) shares made a new 52-week low of $0.59 on Thursday. The stock was down 2.47% for the day.
    • Synaptogenix (NASDAQ:SNPX) shares fell to $0.65 on Thursday, setting a new 52-week low with a shift of down 4.26%.
    • 180 Life Sciences (NASDAQ:ATNF) shares made a new 52-week low of $0.83 on Thursday. The stock was down 2.87% for the day.
    • TransCode Therapeutics (NASDAQ:RNAZ) stock set a new 52-week low of $1.88 on Thursday, moving down 4.54%.
    • Ault Alliance (AMEX:AULT) shares set a new yearly low of $2.40 this morning. The stock was down 7.09% on the session.
    • Bio-Path Hldgs (NASDAQ:BPTH) stock dropped to a yearly low on Thursday of $0.37. Shares traded down 49.43%.
    • Oblong (NASDAQ:OBLG) stock achieved a new 52-week low on Thursday morning, hitting $1.03 and moving down 0.89%.
    • Aditxt (NASDAQ:ADTX) shares fell to $0.38 on Thursday, setting a new 52-week low with a shift of down 3.99%.
    • AgriFORCE Growing Systems (NASDAQ:AGRI) stock set a new 52-week low of $0.11 on Thursday, moving up 10.78%.
    • Blue Star Foods (NASDAQ:BSFC) stock hit a new 52-week low of $0.82. The stock was down 3.36% on the session.
    • Galmed Pharmaceuticals (NASDAQ:GLMD) shares moved down 0.94% on Thursday to hit a new 52-week low of $1.03, drifting down 0.94%.
    • NeuBase Therapeutics (NASDAQ:NBSE) shares were down 16.4% for the day, having made a 52-week low of $0.86.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $WLGS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WLGS
    $WPC
    $XNCR
    $ZI

    CompanyDatePrice TargetRatingAnalyst
    Ormat Technologies Inc.
    $ORA
    2/27/2026$131.00 → $125.00Buy
    TD Cowen
    Zevia PBC
    $ZVIA
    2/26/2026$6.00 → $5.00Outperform
    Telsey Advisory Group
    Pfizer Inc.
    $PFE
    2/25/2026$25.00Underperform
    RBC Capital Mkts
    Pfizer Inc.
    $PFE
    2/20/2026$25.00Underweight
    Barclays
    Beam Therapeutics Inc.
    $BEAM
    2/20/2026$74.00Buy
    Canaccord Genuity
    Ormat Technologies Inc.
    $ORA
    2/13/2026$130.00Buy → Hold
    Jefferies
    Pfizer Inc.
    $PFE
    2/12/2026$27.00Outperform → Neutral
    Daiwa Securities
    Impinj Inc.
    $PI
    2/6/2026$112.00Outperform → In-line
    Evercore ISI
    More analyst ratings

    $WLGS
    $WPC
    $XNCR
    $ZI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Ormat Tech with a new price target

    TD Cowen reiterated coverage of Ormat Tech with a rating of Buy and set a new price target of $125.00 from $131.00 previously

    2/27/26 8:09:52 AM ET
    $ORA
    Electric Utilities: Central
    Utilities

    Telsey Advisory Group reiterated coverage on Zevia PBC with a new price target

    Telsey Advisory Group reiterated coverage of Zevia PBC with a rating of Outperform and set a new price target of $5.00 from $6.00 previously

    2/26/26 6:51:04 AM ET
    $ZVIA
    Beverages (Production/Distribution)
    Consumer Staples

    RBC Capital Mkts initiated coverage on Pfizer with a new price target

    RBC Capital Mkts initiated coverage of Pfizer with a rating of Underperform and set a new price target of $25.00

    2/25/26 7:53:28 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $WLGS
    $WPC
    $XNCR
    $ZI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Vice President Lankler Douglas M exercised 122,907 shares at a strike of $33.82 and covered exercise/tax liability with 119,009 shares, increasing direct ownership by 2% to 163,177 units (SEC Form 4)

    4 - PFIZER INC (0000078003) (Issuer)

    2/27/26 6:35:09 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Executive Vice President Sahni Payal exercised 56,888 shares at a strike of $33.82 and covered exercise/tax liability with 55,149 shares, increasing direct ownership by 7% to 27,667 units (SEC Form 4)

    4 - PFIZER INC (0000078003) (Issuer)

    2/27/26 6:35:10 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SVP & Controller Damico Jennifer B. exercised 17,558 shares at a strike of $33.82 and covered exercise/tax liability with 17,048 shares, increasing direct ownership by 4% to 12,696 units (SEC Form 4)

    4 - PFIZER INC (0000078003) (Issuer)

    2/27/26 6:35:07 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $WLGS
    $WPC
    $XNCR
    $ZI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Siokas Grigorios bought $145,000 worth of shares (388,532 units at $0.37), increasing direct ownership by 5% to 8,861,914 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/13/26 10:05:37 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $120,000 worth of shares (291,262 units at $0.41), increasing direct ownership by 4% to 8,473,382 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/12/26 2:20:08 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    President and CEO Fernandez Raul J bought $250,706 worth of shares (16,446 units at $15.24), increasing direct ownership by 2% to 816,001 units (SEC Form 4)

    4 - DXC Technology Co (0001688568) (Issuer)

    2/3/26 5:55:04 PM ET
    $DXC
    EDP Services
    Technology

    $WLGS
    $WPC
    $XNCR
    $ZI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates

    BRANFORD, Conn., Feb. 27, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the full year ended December 31, 2025, and provided a business update. FY 2025 and Recent Business HighlightsInitiated Phase 1/2 Trial for ATR-04 program targeting oncology patients with EGFRi-associated rash; presented ATR-04 trial design and update at ASCO 2025Announced positive preclinical data for ATR-01 program, targeting the treatment of ichth

    2/27/26 5:30:00 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Novocure to Participate in 2026 Leerink Global Healthcare Conference

    Novocure (NASDAQ:NVCR) announced today that management will participate in the Leerink Global Healthcare Conference on Tuesday, March 10, 2026. Frank Leonard, Chief Executive Officer, and Christoph Brackmann, Chief Financial Officer, will take part in a fireside chat at 11:20 a.m. EST, as well as one-on-one meetings with investors throughout the event. A live audio webcast of this presentation can be accessed from the Investor Relations page of Novocure's website, www.novocure.com/investor-relations, and will be available for replay for at least 14 days following the event. About Novocure Novocure is a global oncology company working to extend survival in some of the most aggressive for

    2/27/26 4:30:00 PM ET
    $NVCR
    Medical/Dental Instruments
    Health Care

    Dakota Gold Announces Appointment of Brian G. Iverson to Board of Directors

    Lead, South Dakota--(Newsfile Corp. - February 27, 2026) - Dakota Gold Corp. (NYSE:DC) ("Dakota Gold" or the "Company") is pleased to announce the appointment of Brian G. Iverson to its Board of Directors ("Board"), effective immediately. Mr. Iverson brings more than three decades of strategic leadership experience across legal, financial, regulatory, and corporate governance functions for South Dakotan companies. Mr. Iverson's local and professional experience compliment the Company's Board as Dakota Gold advances its exploration and development initiatives in South Dakota's historic Homestake District.Mr. Iverson currently serves as General Counsel and Senior Vice President Regulatory and

    2/27/26 6:30:00 AM ET
    $BKH
    $DC
    Electric Utilities: Central
    Utilities
    Metal Mining
    Basic Materials

    $WLGS
    $WPC
    $XNCR
    $ZI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 25, 2024 - FDA Roundup: October 25, 2024

    For Immediate Release: October 25, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA updated the advisory for the outbreak of E. coli O157:H7. A specific ingredient has not yet been confirmed as the source of the outbreak, but most sick people report eating McDonald’s Quarter Pounder burgers. Investigators are working to deter

    10/25/24 2:48:21 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    FDA Approval for HYMPAVZI issued to PFIZER INC

    Submission status for PFIZER INC's drug HYMPAVZI (ORIG-1) with active ingredient MARSTACIMAB-HNCQ has changed to 'Approval' on 10/11/2024. Application Category: BLA, Application Number: 761369, Application Classification:

    10/15/24 2:57:27 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $WLGS
    $WPC
    $XNCR
    $ZI
    SEC Filings

    View All

    Azitra Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Azitra, Inc. (0001701478) (Filer)

    2/27/26 5:02:57 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Azitra Inc

    10-K - Azitra, Inc. (0001701478) (Filer)

    2/27/26 5:02:15 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: Braemar Hotels & Resorts Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K/A - Braemar Hotels & Resorts Inc. (0001574085) (Filer)

    2/27/26 4:54:36 PM ET
    $BHR
    Real Estate Investment Trusts
    Real Estate

    $WLGS
    $WPC
    $XNCR
    $ZI
    Leadership Updates

    Live Leadership Updates

    View All

    Dakota Gold Announces Appointment of Brian G. Iverson to Board of Directors

    Lead, South Dakota--(Newsfile Corp. - February 27, 2026) - Dakota Gold Corp. (NYSE:DC) ("Dakota Gold" or the "Company") is pleased to announce the appointment of Brian G. Iverson to its Board of Directors ("Board"), effective immediately. Mr. Iverson brings more than three decades of strategic leadership experience across legal, financial, regulatory, and corporate governance functions for South Dakotan companies. Mr. Iverson's local and professional experience compliment the Company's Board as Dakota Gold advances its exploration and development initiatives in South Dakota's historic Homestake District.Mr. Iverson currently serves as General Counsel and Senior Vice President Regulatory and

    2/27/26 6:30:00 AM ET
    $BKH
    $DC
    Electric Utilities: Central
    Utilities
    Metal Mining
    Basic Materials

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board

    WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ:TECX) ("Tectonic"), a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced it has appointed François Nader, M.D., MBA, as an independent director to its Board of Directors, effective April 1, 2026, at which time he will also assume the role of Chair of the Board. Dr. Nader brings more than 30 years of leadership experience across the biotechnology and pharmaceutical industry and currently serves as an Independent Director of Moderna, Inc. (NASDAQ:MRNA), a glo

    2/23/26 4:01:00 PM ET
    $MRNA
    $TECX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $WLGS
    $WPC
    $XNCR
    $ZI
    Financials

    Live finance-specific insights

    View All

    NW Natural Holdings Delivers Record 2025 Results Across All Businesses

    Northwest Natural Holding Company (NYSE:NWN) (NW Natural Holdings) reported financial results and highlights including: 2025 Highlights Reported earnings per share (EPS) of $2.77 and record adjusted EPS1 of $2.93 for 2025, compared to EPS of $2.03 and adjusted EPS1 of $2.33 for 2024 Added approximately 98,000 gas and water utility connections in the last 12 months for a combined growth rate of 11.1% as of Dec. 31, 2025, mainly driven by the acquisition of SiEnergy Invested a record $467 million in our utility systems to support greater reliability and resiliency Increased our dividend for the 70th consecutive year in November 2025 2026 Guidance and Long-term Growth Targets

    2/27/26 6:00:00 AM ET
    $NWN
    Oil/Gas Transmission
    Utilities

    Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update

    Full year 2025 net revenues of $655 million and fourth quarter net revenues of $174 million Optune Pax® approved by the U.S. FDA for the treatment of locally advanced pancreatic cancer, commercial launch underway Novocure (NASDAQ:NVCR) today reported financial results for the quarter and full year ended December 31, 2025. Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy, Tumor Treating Fields (TTFields). "In 2025, a record number of patients received treatment with Novocure's Tumor Treating Fields therapy, a milestone that reflects our growth and commitment to advanc

    2/26/26 7:00:00 AM ET
    $NVCR
    Medical/Dental Instruments
    Health Care

    Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance

    Revenue and Adjusted EBITDA results delivered in line with stated full-year targetsFull‑year cost savings exceeded previously communicated targets Highlights: Revenues of $660.5 million for the fourth quarter and $2,723.4 million for the full yearFourth-quarter book-to-bill ratio of 1.14x, resulting in 1.02x book-to-bill for the trailing 12 monthsGAAP net loss of $(32.5) million, or $(0.35) per diluted share for the fourth quarter; $(986.2) million, or $(10.81) per diluted share for the full yearAdjusted EBITDA of $54.0 million for the fourth quarter and $189.9 million for the full yearAdjusted net income of $9.2 million, or $0.09 per diluted share for the fourth quarter; $40.4 million, or

    2/26/26 6:00:00 AM ET
    $FTRE
    Medical Specialities
    Health Care

    $WLGS
    $WPC
    $XNCR
    $ZI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

    SC 13D/A - ModivCare Inc (0001220754) (Subject)

    12/13/24 9:05:42 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

    SC 13D/A - ModivCare Inc (0001220754) (Subject)

    12/13/24 5:07:48 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary